KRT8P18: A Potential Drug Target and Biomarker (G442078)

Target Name: KRT8P18

NCBI ID: G442078

KRT8P18

Other Name(s): keratin 8 pseudogene 18 | Keratin 8 pseudogene 18

KRT8P18: A Potential Drug Target and Biomarker

Keratin is a protein that plays a crucial role in the structure and function of hair and nails. It is a complex protein that consists of multiple isoforms, each with a different size and function. One of the isoforms, KRT8P18, has been identified as a potential drug target and biomarker in the field of skin and hair diseases.

The KRT8P18 gene is located on chromosome 16 and encodes a protein that is expressed in different tissues and cells of the body. It is a member of the keratin gene family, which is known for the production of proteins that are involved in the structure and maintenance of hair and nail growth.

KRT8P18 has been shown to be involved in a number of different processes that are important for hair and nail growth. For example, it has been shown to play a role in the development and maintenance of the cuticle, the outer layer of the hair, and it has been shown to help regulate the growth and differentiation of hair follicles.

In addition to its role in hair and nail growth, KRT8P18 has also been shown to be involved in the regulation of cell signaling pathways that are important for the development and maintenance of tissues and organs. For example, it has been shown to play a role in the regulation of the Wnt signaling pathway, a pathway that is important for the development and maintenance of tissues and organs during embryonic development and throughout life.

Given the role that KRT8P18 plays in the development and maintenance of hair and nails, it is a potential drug target that could be targeted by small molecules or other therapeutic agents. Studies have shown that the KRT8P18 gene is highly expressed in tissues and cells of the body, including hair follicles, and that it is involved in the production of proteins that are involved in the development and maintenance of these tissues.

In addition to its potential as a drug target, KRT8P18 has also been shown to be a potential biomarker for the diagnosis and progression of skin and hair diseases. For example, studies have shown that KRT8P18 is downregulated in the skin and hair of individuals with certain forms of cancer, such as skin cancer and breast cancer, and that it is associated with the development of these diseases.

Furthermore, KRT8P18 has also been shown to be involved in the regulation of cellular processes that are important for the maintenance of tissue homeostasis. For example, it has been shown to play a role in the regulation of the production of collagen, a protein that is involved in the structure and maintenance of tissue extracellular matrix.

In conclusion, KRT8P18 is a protein that is involved in a number of different processes that are important for hair and nail growth and the maintenance of tissues and organs. As a potential drug target and biomarker, KRT8P18 is a promising target for the development of new therapies for skin and hair diseases. Further research is needed to fully understand the role that KRT8P18 plays in these processes and to develop effective treatments.

Protein Name: Keratin 8 Pseudogene 18

The "KRT8P18 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KRT8P18 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets